Article

Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy

Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Rheumatology (Oxford, England) (Impact Factor: 4.44). 09/2008; 47(11):1671-7. DOI: 10.1093/rheumatology/ken328
Source: PubMed

ABSTRACT To describe the clinical features and outcomes of patients with primary central nervous system vasculitis (PCNSV) and cerebral amyloid angiopathy (CAA) from a large cohort of consecutive patients with PCNSV treated at a single institution.
We identified 101 consecutive patients with PCNSV admitted between January 1983 and December 2003. PCNSV diagnoses were based on findings from a central nervous system (CNS) biopsy (n = 31) and conventional angiography (n = 70). CNS tissue specimens from 49 cases were examined histologically, and 49 were stained for amyloid deposits. Those with vascular amyloid deposits (CAA) were compared with those without histological evidence of amyloid deposition.
Eight cases (26%) with CNS biopsy specimens positive for PCNSV also showed findings of CAA. Compared with patients with PCNSV only, these patients were older at diagnosis, predominantly male, had a more acute onset, a higher frequency of cognitive dysfunction and showed prominent gadolinium-enhanced leptomeningeal lesions with MRI. Histologically, all had a granulomatous vascular inflammatory pattern. Six patients responded promptly to therapy. Outcomes at last follow-up were similar in the two groups.
PCNSV with CAA appears to form a clinical subset of PCNSV. The vasculitis influences the clinical findings to a greater degree than the presence of amyloid deposits in the vessels.

0 Bookmarks
 · 
224 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Primary angiitis of the central nervous system (PACNS) is a rare form of vasculitis of unknown aetiology. Multifaceted clinical manifestations, non-specific MRI findings, a broad range of differential diagnoses and diverse pathological appearances prove to be a diagnostic challenge. However, a prompt diagnosis and aggressive treatment are crucial to avoid permanent damage. Hence, we present the clinico-pathological spectrum of this entity and highlight the limitations of currently available diagnostic modalities. We describe in detail the histopathological findings of eight cases of PACNS diagnosed at the Department of Pathology, AIIMS, over a period of eight years. Eight cases of PACNS were identified during this period. Five cases (62.5%) showed features of granulomatous vasculitis, two (25%) showed lymphocytic vasculitis and one case (12.5%) showed a predominantly necrotizing pattern of vasculitis. Diagnosis of PACNS is a challenge and requires a high index of clinical suspicion. Appropriate work-up to exclude other conditions is mandatory. Brain biopsy is useful in making the diagnosis and ruling out mimicking conditions.
    Folia Neuropathologica 01/2014; 52(2):187-96. DOI:10.5114/fn.2014.43790 · 1.67 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective. To describe the treatment and outcomes in primary central nervous system vasculitis (PCNSV). Methods. We retrospectively studied a cohort of 163 consecutive patients with PCNSV seen at the Mayo Clinic over a 29-year period. We analyzed treatments and responses, and factors predictive of outcomes. Results. 85% of patients treated with prednisone alone responded favorably as did 80% of those given prednisone and cyclophosphamide. Relapses were observed in 27% of patients. 25% had discontinued therapy by last follow-up. Treatment with prednisone alone was associated with more frequent relapses (OR, 2.90), while large vessel involvement (OR, 6.14) and cerebral infarcts at diagnosis (OR, 3.32) were associated with poor response to treatment. Prominent gadolinium-enhanced lesions or meninges (OR, 2.28) were linked with continued treatment at last follow-up. Higher disability scores at last follow-up were associated with increasing age at diagnosis (OR, 1.44), and cerebral infarctions (OR, 3.74), while lower disability scores were associated with gadolinium enhanced cerebral lesions or meninges (OR, 0.35) and cerebral amyloid angiopathy (OR, 0.24). Increased mortality was associated with increasing age at diagnosis (HR 1.39), diagnosis by angiography (HR 3.28), cerebral infarction (HR, 4.44), and large cerebral vessel involvement (HR, 4.98), while reduced mortality with gadolinium enhanced cerebral lesions or meninges (HR, 0.20). Conclusion. The majority of patients with PCNSV responded to treatment. Recognition of findings at diagnosis which predict course or outcome may aid decisions regarding therapy. This article is protected by copyright. All rights reserved. Copyright © 2015 American College of Rheumatology.
    02/2015; DOI:10.1002/art.39068
  • [Show abstract] [Hide abstract]
    ABSTRACT: Primary angiitis of the central nervous system (PACNS) is a rare disease, although it is increasingly recognized both in adults and children. Little is known about pathogenesis, but efforts at classification into subtypes are being made, and the distinction of PACNS from reversible cerebral vasoconstriction syndrome has been a major advance. The prognosis for improvement, or at least stabilization, of neurologic function is good with prompt and aggressive treatment, but the diagnosis continues to be challenging. Refinement of treatment strategies is needed. Multicenter collaboration may be crucial to make additional progress via randomized trials.
    Rheumatic diseases clinics of North America 02/2015; 41(1):47-62. DOI:10.1016/j.rdc.2014.09.004 · 2.59 Impact Factor

Full-text (2 Sources)

Download
67 Downloads
Available from
May 30, 2014